decision analytic microsimulation model Search Results


pro 2020  (treeage software)
90
treeage software pro 2020
Pro 2020, supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pro 2020/product/treeage software
Average 90 stars, based on 1 article reviews
pro 2020 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
software version 9.4  (SAS institute)
90
SAS institute software version 9.4
Conceptual diagram of the simulation model. <t>ASCVD,</t> atherosclerotic cardiovascular disease; QALYs, Quality adjusted life years, ICER, incremental cost effectiveness ratio. *, People suffered from ASCVD in 10 year among the cohort population. †, Less people developed ASCVD in the cohort after intervention compared to the scenario of no intervention. ‡, Costs before intervention included: per capita total expenditure on health, hospitalization and post-event outpatient ASCVD management costs, and indirect costs due to onset of ASCVD. §, Costs after intervention included: costs before intervention, <t>statin</t> treatment related cost and side effects treatment costs. ||, Under statin treatment, the statin treatment related adverse effects would decrease quality of life and incur treatment cost for people who receive statin treatment.
Software Version 9.4, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/software version 9.4/product/SAS institute
Average 90 stars, based on 1 article reviews
software version 9.4 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
decision analytic markov microsimulation model  (treeage software)
90
treeage software decision analytic markov microsimulation model
Conceptual diagram of the simulation model. <t>ASCVD,</t> atherosclerotic cardiovascular disease; QALYs, Quality adjusted life years, ICER, incremental cost effectiveness ratio. *, People suffered from ASCVD in 10 year among the cohort population. †, Less people developed ASCVD in the cohort after intervention compared to the scenario of no intervention. ‡, Costs before intervention included: per capita total expenditure on health, hospitalization and post-event outpatient ASCVD management costs, and indirect costs due to onset of ASCVD. §, Costs after intervention included: costs before intervention, <t>statin</t> treatment related cost and side effects treatment costs. ||, Under statin treatment, the statin treatment related adverse effects would decrease quality of life and incur treatment cost for people who receive statin treatment.
Decision Analytic Markov Microsimulation Model, supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/decision analytic markov microsimulation model/product/treeage software
Average 90 stars, based on 1 article reviews
decision analytic markov microsimulation model - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
treeage pro 2022  (treeage software)
90
treeage software treeage pro 2022
Conceptual diagram of the simulation model. <t>ASCVD,</t> atherosclerotic cardiovascular disease; QALYs, Quality adjusted life years, ICER, incremental cost effectiveness ratio. *, People suffered from ASCVD in 10 year among the cohort population. †, Less people developed ASCVD in the cohort after intervention compared to the scenario of no intervention. ‡, Costs before intervention included: per capita total expenditure on health, hospitalization and post-event outpatient ASCVD management costs, and indirect costs due to onset of ASCVD. §, Costs after intervention included: costs before intervention, <t>statin</t> treatment related cost and side effects treatment costs. ||, Under statin treatment, the statin treatment related adverse effects would decrease quality of life and incur treatment cost for people who receive statin treatment.
Treeage Pro 2022, supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/treeage pro 2022/product/treeage software
Average 90 stars, based on 1 article reviews
treeage pro 2022 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
pro 2014 software  (treeage software)
90
treeage software pro 2014 software
Conceptual diagram of the simulation model. <t>ASCVD,</t> atherosclerotic cardiovascular disease; QALYs, Quality adjusted life years, ICER, incremental cost effectiveness ratio. *, People suffered from ASCVD in 10 year among the cohort population. †, Less people developed ASCVD in the cohort after intervention compared to the scenario of no intervention. ‡, Costs before intervention included: per capita total expenditure on health, hospitalization and post-event outpatient ASCVD management costs, and indirect costs due to onset of ASCVD. §, Costs after intervention included: costs before intervention, <t>statin</t> treatment related cost and side effects treatment costs. ||, Under statin treatment, the statin treatment related adverse effects would decrease quality of life and incur treatment cost for people who receive statin treatment.
Pro 2014 Software, supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pro 2014 software/product/treeage software
Average 90 stars, based on 1 article reviews
pro 2014 software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
model vga-77 hydride generator  (Varian Medical)
90
Varian Medical model vga-77 hydride generator
Conceptual diagram of the simulation model. <t>ASCVD,</t> atherosclerotic cardiovascular disease; QALYs, Quality adjusted life years, ICER, incremental cost effectiveness ratio. *, People suffered from ASCVD in 10 year among the cohort population. †, Less people developed ASCVD in the cohort after intervention compared to the scenario of no intervention. ‡, Costs before intervention included: per capita total expenditure on health, hospitalization and post-event outpatient ASCVD management costs, and indirect costs due to onset of ASCVD. §, Costs after intervention included: costs before intervention, <t>statin</t> treatment related cost and side effects treatment costs. ||, Under statin treatment, the statin treatment related adverse effects would decrease quality of life and incur treatment cost for people who receive statin treatment.
Model Vga 77 Hydride Generator, supplied by Varian Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/model vga-77 hydride generator/product/Varian Medical
Average 90 stars, based on 1 article reviews
model vga-77 hydride generator - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
microsimulation  (MathWorks Inc)
90
MathWorks Inc microsimulation
Inclusion and exclusion criteria applied in the study
Microsimulation, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microsimulation/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
microsimulation - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
compare microsimulation model  (RAND Corporation)
90
RAND Corporation compare microsimulation model
Inclusion and exclusion criteria applied in the study
Compare Microsimulation Model, supplied by RAND Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/compare microsimulation model/product/RAND Corporation
Average 90 stars, based on 1 article reviews
compare microsimulation model - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
microsimulation model  (Credence Genomics)
90
Credence Genomics microsimulation model
Inclusion and exclusion criteria applied in the study
Microsimulation Model, supplied by Credence Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microsimulation model/product/Credence Genomics
Average 90 stars, based on 1 article reviews
microsimulation model - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
spatial microsimulation  (Cullinan Oncology)
90
Cullinan Oncology spatial microsimulation
Inclusion and exclusion criteria applied in the study
Spatial Microsimulation, supplied by Cullinan Oncology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spatial microsimulation/product/Cullinan Oncology
Average 90 stars, based on 1 article reviews
spatial microsimulation - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
compas microsimulation model  (COMPAS Inc)
90
COMPAS Inc compas microsimulation model
Inclusion and exclusion criteria applied in the study
Compas Microsimulation Model, supplied by COMPAS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/compas microsimulation model/product/COMPAS Inc
Average 90 stars, based on 1 article reviews
compas microsimulation model - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
markov microsimulation model  (Novartis)
90
Novartis markov microsimulation model
Characteristics of included studies.
Markov Microsimulation Model, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/markov microsimulation model/product/Novartis
Average 90 stars, based on 1 article reviews
markov microsimulation model - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Conceptual diagram of the simulation model. ASCVD, atherosclerotic cardiovascular disease; QALYs, Quality adjusted life years, ICER, incremental cost effectiveness ratio. *, People suffered from ASCVD in 10 year among the cohort population. †, Less people developed ASCVD in the cohort after intervention compared to the scenario of no intervention. ‡, Costs before intervention included: per capita total expenditure on health, hospitalization and post-event outpatient ASCVD management costs, and indirect costs due to onset of ASCVD. §, Costs after intervention included: costs before intervention, statin treatment related cost and side effects treatment costs. ||, Under statin treatment, the statin treatment related adverse effects would decrease quality of life and incur treatment cost for people who receive statin treatment.

Journal: Global Heart

Article Title: Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease

doi: 10.5334/gh.830

Figure Lengend Snippet: Conceptual diagram of the simulation model. ASCVD, atherosclerotic cardiovascular disease; QALYs, Quality adjusted life years, ICER, incremental cost effectiveness ratio. *, People suffered from ASCVD in 10 year among the cohort population. †, Less people developed ASCVD in the cohort after intervention compared to the scenario of no intervention. ‡, Costs before intervention included: per capita total expenditure on health, hospitalization and post-event outpatient ASCVD management costs, and indirect costs due to onset of ASCVD. §, Costs after intervention included: costs before intervention, statin treatment related cost and side effects treatment costs. ||, Under statin treatment, the statin treatment related adverse effects would decrease quality of life and incur treatment cost for people who receive statin treatment.

Article Snippet: The China statin decision ASCVD microsimulation model was developed in SAS software (version 9.4, SAS Institute, Cary, NC, USA).

Techniques:

Criterions and parameters of statin treatment recommendation for people with different risk.

Journal: Global Heart

Article Title: Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease

doi: 10.5334/gh.830

Figure Lengend Snippet: Criterions and parameters of statin treatment recommendation for people with different risk.

Article Snippet: The China statin decision ASCVD microsimulation model was developed in SAS software (version 9.4, SAS Institute, Cary, NC, USA).

Techniques:

Cost-effectiveness of statin treatment among people with different risk of ASCVD. Data are incremental cost-effectiveness ratios (Int$ per QALY gained). ASCVD, atherosclerotic cardiovascular disease; ICER, incremental cost-effectiveness ratio. In healthcare sector perspective direct cost such as change of ASCVD treatment cost due to decrease of ASCVD incidence, statin medicine cost, statin treatment related cost, routine healthcare cost, and adverse events treatment cost were included. In societal perspective both direct and indirect costs were included. The indirect cost included patient-time costs, unpaid caregiver-time, transportation costs, and labor market earnings lost.

Journal: Global Heart

Article Title: Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease

doi: 10.5334/gh.830

Figure Lengend Snippet: Cost-effectiveness of statin treatment among people with different risk of ASCVD. Data are incremental cost-effectiveness ratios (Int$ per QALY gained). ASCVD, atherosclerotic cardiovascular disease; ICER, incremental cost-effectiveness ratio. In healthcare sector perspective direct cost such as change of ASCVD treatment cost due to decrease of ASCVD incidence, statin medicine cost, statin treatment related cost, routine healthcare cost, and adverse events treatment cost were included. In societal perspective both direct and indirect costs were included. The indirect cost included patient-time costs, unpaid caregiver-time, transportation costs, and labor market earnings lost.

Article Snippet: The China statin decision ASCVD microsimulation model was developed in SAS software (version 9.4, SAS Institute, Cary, NC, USA).

Techniques:

Cost-effectiveness of statin treatment vs. no statin treatment over 10 years stratified by ASCVD risk from health-care sector perspective and using statin prices from the new centralized medicine procurement policy.

Journal: Global Heart

Article Title: Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease

doi: 10.5334/gh.830

Figure Lengend Snippet: Cost-effectiveness of statin treatment vs. no statin treatment over 10 years stratified by ASCVD risk from health-care sector perspective and using statin prices from the new centralized medicine procurement policy.

Article Snippet: The China statin decision ASCVD microsimulation model was developed in SAS software (version 9.4, SAS Institute, Cary, NC, USA).

Techniques:

Estimated 10-year treatment effect and direct costs change among 35–64 years old ASCVD-free people if the new centralized medicine procurement policy implemented in the whole nation.

Journal: Global Heart

Article Title: Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease

doi: 10.5334/gh.830

Figure Lengend Snippet: Estimated 10-year treatment effect and direct costs change among 35–64 years old ASCVD-free people if the new centralized medicine procurement policy implemented in the whole nation.

Article Snippet: The China statin decision ASCVD microsimulation model was developed in SAS software (version 9.4, SAS Institute, Cary, NC, USA).

Techniques:

Proportion of outpatient costs of low-dose statins treatment for people without ASCVD by risk level. ASCVD, atherosclerotic cardiovascular disease. Low-dose statins: simvastatin 20 mg/day, atorvastatin 10 mg/day, or rosuvastatin 5 mg/day.

Journal: Global Heart

Article Title: Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease

doi: 10.5334/gh.830

Figure Lengend Snippet: Proportion of outpatient costs of low-dose statins treatment for people without ASCVD by risk level. ASCVD, atherosclerotic cardiovascular disease. Low-dose statins: simvastatin 20 mg/day, atorvastatin 10 mg/day, or rosuvastatin 5 mg/day.

Article Snippet: The China statin decision ASCVD microsimulation model was developed in SAS software (version 9.4, SAS Institute, Cary, NC, USA).

Techniques:

Cost-effectiveness acceptability curves for people with different 10-year ASCVD risk treated with different dose of statin.

Journal: Global Heart

Article Title: Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease

doi: 10.5334/gh.830

Figure Lengend Snippet: Cost-effectiveness acceptability curves for people with different 10-year ASCVD risk treated with different dose of statin.

Article Snippet: The China statin decision ASCVD microsimulation model was developed in SAS software (version 9.4, SAS Institute, Cary, NC, USA).

Techniques:

Inclusion and exclusion criteria applied in the study

Journal: BMC Health Services Research

Article Title: Application of decision analytical models to diabetes in low- and middle-income countries: a systematic review

doi: 10.1186/s12913-022-08820-7

Figure Lengend Snippet: Inclusion and exclusion criteria applied in the study

Article Snippet: MATLAB was used to implement microsimulation [ ] and Markov models [ ].

Techniques:

Modelling details in CHEERs checklist reported in reviewed studies

Journal: BMC Health Services Research

Article Title: Application of decision analytical models to diabetes in low- and middle-income countries: a systematic review

doi: 10.1186/s12913-022-08820-7

Figure Lengend Snippet: Modelling details in CHEERs checklist reported in reviewed studies

Article Snippet: MATLAB was used to implement microsimulation [ ] and Markov models [ ].

Techniques: Biomarker Discovery

Characteristics of included studies.

Journal: Osteoporosis and Sarcopenia

Article Title: Systematic evidence of health economic evaluation of drugs for postmenopausal osteoporosis: A quality appraisal

doi: 10.1016/j.afos.2020.05.006

Figure Lengend Snippet: Characteristics of included studies.

Article Snippet: 19 , Hiligsmann [ ], 2010 , Belgium , Potential clinical and economic impact of nonadherence with osteoporosis medications , CEA , Healthcare payer , QALY , Markov microsimulation model , Lifetime , 3%, 1.5% , Novartis.

Techniques: Biomarker Discovery, Medications, Comparison, Injection